The high economic burden
of preeclampsia

We collaborated with Geisinger to perform the first study using primary data to uncover the economic burden of preeclampsia.

Preeclampsia is a growing issue, but little is known about the cost to our healthcare system.

In a collaboration between Progenity and Geisinger, a large regional healthcare system, >2,100 mother/infant pairs were matched and evenly distributed among three cohorts of normal, hypertensive, and preeclamptic pregnancies. Primary data from their Geisinger electronic medical and billing records was used to estimate differences in their healthcare costs.

This research was presented at SMFM, and was subsequently published in Obstetrics & Gynecology.

What did we find?

  • Preeclamptic pregnancies were on average $28,603 more costly than normal pregnancies and $17,608 more costly than hypertensive pregnancies (2015 U.S. dollars).1
  • The mean infant cost in the preeclamptic pregnancies was $28,898, almost 8 times greater than for the normal cohort of $3,669 and more than double the hypertension cohort of $12,648 (2015 U.S. dollars).1
The healthcare costs of preeclampsia are significant and primarily driven by high infant costs linked to premature delivery (3 weeks earlier compared to normal and more than 2 weeks earlier for hypertension) and other adverse events. Additionally, women with preeclampsia had higher rates of C-section deliveries and maternal adverse events.1
This research was published in the December 2019 issue of Obstetrics & Gynecology. Read the publication
This research was initially presented at the 2019 Society for Maternal-Fetal Medicine (SMFM) Annual Pregnancy Meeting. Download the poster


  1. Hao J, Hassen D, Hao Q, et al. Maternal and Infant Health Care Costs Related to Preeclampsia. Obstet Gynecol. 2019;134(6):1227-1233. doi:10.1097/AOG.0000000000003581